SPECIAL EMPHASIS PANELS
To view other meetings from ZHL1 choose calendar year:
Study Section | Panel Name | Meeting Rosters |
---|---|---|
ZHL1 PPG-F(O1) | GENETICS AND BIOLOGY OF VON WILLEBRAND DISEASE | 05/08/24 |
ZHL1 CCT-Q(C2) | HISPANIC COMMUNITY HEALTH STUDY - STUDY OF LATINOS (HCHS-SOL) FIELD CENTERS | 05/02/24 |
ZHL1 CCT-Q(C1) | HISPANIC COMMUNITY HEALTH STUDY - STUDY OF LATINOS (HCHS-SOL) COORDINATING CENTER | 04/30/24 |
ZHL1 PPG-C(M1) | NEONATAL TRANSFUSION | 04/15/24 |
ZHL1 CCT-D(C1) | NHLBI CONTRACT REVIEW | 04/11/24 |
ZHL1 CSR-N(M1) | GRANT REVIEW FOR NHLBI K AWARD RECIPIENTS (R03) | 04/03/24 |
ZHL1 CSR-O(M1) | CATALYZE ENABLING TECHNOLOGIES | 04/02/24 |
ZHL1 CSR-O(M2) | CATALYZE PRODUCT DEVELOPMENT | 03/29/24 |
ZHL1 CSR-O(M3) | NHLBI MENTORED CAREER DEVELOPMENT K-AWARDS | 03/28/24 |
ZHL1 CSR-I(M3) | K38 REVIEW MEETING | 03/27/24 |
ZHL1 CSR-Z(M2) | DIABETES-SLEEP AND CARDIOVASCULAR RISK (R01/R34) | 03/21/24 |
ZHL1 CSR-O(M4) | R13 CONFERENCE GRANTS | 03/21/24 |
ZHL1 CSR-K(M1) | NHLBI BIOREPOSITORY: SCIENTIFIC OPPORTUNITIES FOR EXPLORATORY RESEARCH (R21) | 03/15/24 |
ZHL1 CSR-Z(M1) | CLINICAL TRIALS SEP (UG3, U24) | 03/14/24 |
ZHL1 CSR-F(M1) | CATALYZE PRODUCT DEFINITION (R61/R33) | 03/13/24 |
ZHL1 CSR-L(M2) | THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK DATA COORDINATING CENTER (U24) REVIEW PANEL | 03/12/24 |
ZHL1 CSR-L(M1) | THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK - CORE CLINICAL CENTERS (UG1) REVIEW PANEL | 03/11/24 |
ZHL1 CSR-A(M1) | MENTORED CAREER DEVELOPMENT AWARD TO PROMOTE FACULTY RESEARCH DIVERSITY | 03/08/24 |
ZHL1 PPG-H(M1) | MOLECULAR PHENOTYPES OF ASTHMA EXACERBATION IN CHILDREN | 03/07/24 |
ZHL1 CSR-Q(M1) | NHLBI TOPMED: OMICS PHENOTYPES OF HEART, LUNG, AND BLOOD DISORDERS (X01) | 03/06/24 |
ZHL1 CSR-F(M2) | EARLY PHASE CLINICAL TRIALS (R61/R33) | 03/01/24 |
ZHL1 CSR-I(M1) | MOLECULAR ATLAS OF LUNG DEVELOPMENT (LUNGMAP) PROGRAM | 03/01/24 |
ZHL1 PPG-L(M1) | NHLBI PROGRAM PROJECT APPLICATIONS (P01) | 02/28/24 |
ZHL1 CSR-N(M2) | MAXIMIZING OPPORTUNITIES FOR SCIENTIFIC AND ACADEMIC INDEPENDENT CAREERS | 02/23/24 |